Catalyst Wire Dossier Catalyst Wire Dossier

Inpegsomatropin

Inpegsomatropin · Xiamen Amoytop Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Inpegsomatropin, covering 2026-03-02 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature [Phase 3]

See pricing